Congress Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Congress Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,400	Closed	-$1.2M	–	393
2023 Q3	$1.2M	Sell	10,400 -1,245	-11%	-$134K	0.01%	302
2023 Q2	$1.2M	Sell	11,645 -47,778	-80%	-$5.04M	0.01%	302
2023 Q1	$6.49M	Sell	59,423 -1,253,712	-95%	-$139M	0.06%	194
2022 Q4	$149M	Sell	1,313,135 -251,611	-16%	-$20.9M	1.5%	5
2022 Q3	$96.8M	Sell	1,564,746 -19,699	-1%	-$1.38M	1.04%	36
2022 Q2	$126M	Sell	1,584,445 -19,416	-1%	-$1.84M	1.21%	16
2022 Q1	$169M	Sell	1,603,861 -11,698	-0.7%	-$1.14M	1.44%	10
2021 Q4	$174M	Sell	1,615,559 -46,547	-3%	-$5.08M	1.33%	16
2021 Q3	$182M	Sell	1,662,106 -51,729	-3%	-$5.37M	1.42%	10
2021 Q2	$160M	Sell	1,713,835 -44,177	-3%	-$4.07M	1.34%	14
2021 Q1	$162M	Sell	1,758,012 -95,445	-5%	-$8.05M	1.46%	9
2020 Q4	$136M	Sell	1,853,457 -26,273	-1%	-$1.95M	1.28%	22
2020 Q3	$146M	Sell	1,879,730 -75,654	-4%	-$5.21M	1.58%	8
2020 Q2	$109M	Buy	1,955,384 +1,717,803	+723%	+$73.5M	1.29%	19
2020 Q1	$7.04M	Sell	237,581 -17,043	-7%	-$577K	0.11%	113
2019 Q4	$9.22M	Sell	254,624 -10,934	-4%	-$335K	0.11%	107
2019 Q3	$7.23M	Sell	265,558 -13,288	-5%	-$344K	0.09%	119
2019 Q2	$6.71M	Sell	278,846 -5,551	-2%	-$141K	0.09%	140
2019 Q1	$7.52M	Buy	+284,397	New	+$6.74M	0.1%	125

Other funds holding HZNP

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $275M AUM 24.94% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Congress Asset Management's HZNP Position: Q4 2023 in Review

Congress Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 10,400 shares — an estimated $1.2M sold.

Congress Asset Management first reported a position in HZNP in Q1 2019 and held it in 19 quarters. The position peaked at $182M in Q3 2021. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Congress Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Congress Asset Management sold 10,400 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $1.2M.
Congress Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2019 and held it in 19 quarters.
Congress Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $182M in Q3 2021.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Congress Asset Management's 13F filing for Q4 2023, filed 4 Mar 2024.